NCT03213639View on ClinicalTrials.gov

Esomeprazole in Treatment of Early Onset Preeclampsia (ESOPE Trial)

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

205

Participants

Timeline

Start Date

March 15, 2018

Primary Completion Date

July 1, 2020

Study Completion Date

October 15, 2020

Conditions
Preeclampsia
Interventions
DRUG

Esomeprazole 40 mg Oral Tablet

once daily oral tablets

DRUG

Placebo Oral Tablet

once daily oral tablets

Trial Locations (1)

Unknown

Assiut Faculty of Medicine, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT03213639 - Esomeprazole in Treatment of Early Onset Preeclampsia (ESOPE Trial) | Biotech Hunter | Biotech Hunter